Patent Oppositions in organic medicines industry

Explore the competitive field of organic medicines where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in organic medicines technology and learn how to protect your intellectual property.

Get Patent Opposition Report for organic medicines

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Oct 23, 2025
CompanyTotal Oppositions
NOVARTIS267
BOEHRINGER INGELHEIM111
PFIZER80
CELGENE66
NUTRICIA60
NESTLE56
JANSSEN PHARMACEUTICA56
AMGEN54
NESTEC51
EURO CELTIQUE43

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the organic medicines industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the organic medicines industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the organic medicines industry

Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 18, 2025GENERICS UK
Methods Of Treating Prostate CancerJANSSEN PHARMACEUTICASep 17, 2025SANDOZ
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 17, 2025POLPHARMA
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECASep 17, 2025GENERICS UK
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 16, 2025WUESTHOFF & WUESTHOFF
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 15, 2025CAMULON
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 12, 2025TEVA PHARMACEUTICALS
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 10, 2025BARDEHLE PAGENBERG
Solid Oral Formulation Of FenretinideLAURENT PHARMACEUTICALSSep 9, 2025WUESTHOFF & WUESTHOFF
Tablets Comprising Eltrombopag OlamineNOVARTISSep 9, 2025ELKINGTON AND FIFE

To stay ahead in the competitive organic medicines industry, companies are constantly innovating. Here are the top patents facing oppositions in the organic medicines industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS23
Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY22
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA20
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Oct 23, 2024New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS18
Oct 11, 2023New UseNOVARTIS17
Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPE15
Mar 8, 2023Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS15
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMA13
Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA12